Platelet-dependent thrombin generation in patients with diabetes mellitus: Effects of glycemic control on coagulability in diabetes

Journal of the American College of Cardiology

Volumn 27, Issue 3, 1996, Pages 560-566

  Aoki, Isao ^a   Shimoyama, Katsuya ^a   Aoki, Nobuo ^a   Homori, Masashi ^a   Yanagisawa, Atsuo ^a   Nakahara, Kazuhiko ^a   Kawai, Yohko ^b   Kitamura, Shin Ichi ^c   Ishikawa, Kyozo ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Department of Internal Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBIN TIME; THROMBOCYTE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD GLUCOSE; BLOOD PLATELETS; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRINOLYSIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; THROMBIN;

EID: 0029921450     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00518-8     Document Type: Article

References (33)

1. Ostcrmann H, van de Loo J. Factors of the hemostatic system in diabetic patients. A survey of controlled studies. Haemostasis 1986;16:386-416.
2. Colwell JA, Halushka PV. Platelet function in diabetes mellitus. Br J Haematol 1980;44:521-6.
3. Di Mario U, Borsey DQ, Contreas G, Prowse CV, Clarke BF, Andreani D. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy. Clin Exp Immunol 1986;65:57-65.
4. Frade LJG, de la Calle H, Alava I, Navarro JL, Creighton LJ, Gaffncy PJ. Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage. Thromb Res 1987;47:533-40.
5. Udvardy M, Torok I, Rak K. Plasma thoromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus. Thromb Res 1987;47:479-84.
6. Ramani A, Kumar S, Tyagi AN. Effect of serum cholesterol on platelet adhesiveness in vascular complications of diabetes mellitus. Indian Heart J 1988;40:144-7.
7. Cho NH, Becker D, Dorman JS, et al. Spontaneous whole blood platelet aggregation in insulin-dependent diabetes mellitus: an evaluation in an epidemiologic study. Thromb Haemostas 1989;61:127-30.
8. Davi G, Catalano I, Averna M, et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990;322:1769-74.
9. Toth L, Szenasi P, Jambor G, Kammerer L, Romics L. Platelet function in male diabetics with and without macrovascular complications. Diabetes Res Clin Pract 1992;15:143-8.
10. Ceriello A, Russo PD, Zuccotti C, Florio A, Pietrantuono C, Rosato GB. Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation - a preliminary report. Thromb Haemostas 1983;50:633-4.
11. Brownlee M, Vlassara H, Cerami A. Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Diabetes 1984;33: 532-5.
12. Small M, Lowe GDO, MacCuish AC, Forbes CD. Thrombin and plasmin activity in diabetes mellitus and their association with glycaemic control. Q J Med 1987;65:1025-31.
13. Villanueva GB, Allen N. Demonstration of altered antithrombin III activity due to nonenzymatic glycosylation at glucose concentration expected to be encountered in severely diabetic patients. Diabetes 1988;37:1103-7.
14. Marongiu F, Conti M, Mameli G, et al. Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity? Thromb Res 1990l58:91-9.
15. Ceriello A, Giugliano D, Quatraro A, Marchi E, Barbanti M, Lefebvre P. Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans. Diabetologia 1990;33:163-7.
16. Rose D, Kotschy M, Rewakovicz M, Listopadzki D. Thrombin/antithrombin III complex in patients with peripheral occlusive arterial disease. Fol Haematol 1990;117:405-11.
17. Van Wersch JWJ, Westerhuis LWJJM, Venekamp WJRR. Coagulation activation in diabetes mellitus. Haemostasia 1990;20:263-9.
18. Carmassi F, Morale M, Puccetti R, et al. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res 1992;67: 643-54.
19. Knaap JH, de Boer AC, Pannebakker MAG, van Hecrde W, den Ottolander GJH. The effect of diabetes regulation on platelet release, fibrinolysis and coagulation tests, before and after stimulation with DDAVP. Thromb Haemostas 1985;53:118-21.
20. Dallinger KJC, Jennings PE, Toop MJ, Gyde OHB, Barnett AH. Platelet aggregation and coagulation factors in insulin dependent diabetics with and without microangiopathy. Diahet Med 1987;4:44-8.
21. Christe M, Fritschi J, Lammle B, et al. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy. Thromb Haemostas 1984;52:138-43.
22. Patrassi GM, Picchinenna R, Vettor R, Cappellato G, Coccarielli D, Girolami A. Antithrombin III activity and concentration in diabetes mellitus. Thromb Haemostas 1985;54:415-7.
23. Zwaal RFA, Comfurius P, Bevers EM. Platelet procoagulant activity and microvesicle formation: its putative role in hemostasis and thrombosis. Biochim Biophys Acta 1992;1180:1-8.
24. Aronson DL, Chang P, Kessler CM. Platelet-dependent thrombin generation after in vitro fibrinolytic treatment. Circulation 1992;85:1706-12.
25. World Health Organization Expert Committee. Second Report on Diabetes Mellitus. Geneva, World Health Organization 1980 (Tech. Rep. Ser., no. 646).
26. Cox AC, Inyangetor P, Esmon CT, White BN. The effect of aggregation and release on platelet prothrombin-converting activity. Blood 1979;54:659-72.
27. Rosing J, van Rijn JLML, Bevers EM, van Dicijen G, Comfurius P, Zwaal RFA. The role of activated human platelets in prothrombin and factor X activation. Blood 985;65:319-32.
28. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990;76:1-16.
29. Shattil SJ, Anaya-Galindo R, Bennett J, Colman RW, Cooper RA. Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest 1975;55: 636-43.
30. 2 synthesis in type IIa hypercholestcrolemic patients. Atherosclerosis 1989;79:79-83.
31. Mazeaud MM, Driss F, Sang K-HLQ, et al. Biochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patients. Atherosclerosis 1992;94:201-11.
32. Wada H, Mori Y, Kaneko T. et al. Hypercoagulable state in patients with hypercholestcrolemia: effects of pravastatin. Clin Ther 1992;14:829-34.
33. Bo M, Bonino F, Neirotti M, et al. Hemorheologic and coagulative pattern in hypercholesterolemic subjects treated with lipid-lowering drugs. Angiology 1991;42:106-13.